Also known as: Neuralink
Neuralink is a private American neurotechnology company developing implantable brain-computer interfaces. Founded in 2016, it is based in Fremont, California.
China became the first country to approve an invasive BCI device for commercial use, while state-backed NeuCyber Neurotech acknowledges its most advanced product lags Neuralink by approximately three years in development.
China's brain-computer interface industry is rapidly commercializing with strong policy support, including an $165 million government fund and provincial medical pricing systems. The market is projected to reach $530 million in 2025 and over 120 billion yuan by 2040.
